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F 11782, or 2″ ,3″ -bis pentafluorophenoxyacetyl-4″ ,6″ -ethylidene-
β -D-glucoside of 4′ -phosphate-4′ -demethylepipodophyllotoxin
2N-methyl glucamine salt (Figure 1), is a novel fluorinated
lipophylic epipodophylloid (Guminski et al, 1999) with a unique
mode of interaction with topoisomerases I and II (Perrin et al,
2000). In vivo, F 11782 has shown markedly superior antitumour
activity against a series of experimental tumour models, compared
to camptothecin or etoposide, respectively, a specific topoiso-
merase I- or topoisomerase II-interacting agent (Kruczynski et al,
1999). At the cellular level, F 11782 proved cytotoxic against a
panel of murine leukaemia and human tumour cell lines, resulting
in an accumulation of cells in the G2/M phases of the cycle, with
an induction of apoptosis (Etiévant et al, 1999). Preliminary
studies using three different methods to detect DNA damage 
and various mammalian cell lines, suggested that cytotoxicity of 
F 11782 might result from the induction of cellular DNA damage
(Barret et al, 1999; Perrin et al, 1999). Moreover, it was suggested
tentatively that the DNA strand breakage induced by F 11782
might differ from that induced by etoposide. In this context,
detailed characterization of DNA damage induced by F 11782
appeared important in elucidating the mode of action of this novel
compound. 
In this present study, the DNA damaging activity of F 11782 in
cultured V79 cells has been characterized using various comet
assay protocols. These results have been compared with those
obtained following exposure to camptothecin or etoposide, tested
concurrently, and used as reference compounds for, respectively,
specific topoisomerase I- and topoisomerase II-interacting agents. 
MATERIALS AND METHODS 
Chemicals and drugs 
F 11782 was synthesized at the Centre de Recherche Pierre 
Fabre (Castres, France) and etoposide were provided by Pierre
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Figure 1 Structure of F11782, or 2”,3”-bis pentafluorophenoxyacetyl1-4”,
6”-ethylidene-β -D-glucoside of 4´-phosphate-4´-demethylepipodophyllotoxin,
2 N-methyl glucamine
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Fabre Médicament (Gaillac, France). Camptothecin was purchased
from Cipla (Bombay, India). F 11782 was solubilized in water
immediately prior to use, whilst etoposide and camptothecin 
were solubilized in dimethyl sulphoxide (DMSO) (SDS, Peypin,
France) and used in assays at a maximal final concentration 
of 0.1%. 
Cell culture and cell treatment 
Chinese hamster lung fibroblastic V79-171b cells were generously
provided by Dr R Durand (British Columbia Cancer Research
Center, Vancouver BC, Canada). This cell line was maintained in
monolayer growth by subcultivation twice weekly in Eagle’s
minimal essential medium (MEM) containing 10% fetal bovine
serum (FBS). For experiments, monolayer V79 cells were
trypsinized for 8 minutes using 0.1% trypsin and then resuspended
in 10 ml complete medium in Petri dishes at a density of 
5  × 105 cells/100 mm dish. After 1 hour, cells were exposed 
to freshly solubilized test compounds and mixed with MEM
containing 10% FBS. V79 spheroids were initiated by seeding 5 ×
104 cells ml–1 into Bellco glass spinner culture vessels containing
MEM plus 5% FBS. Spheroids were fed after 3 days and daily
thereafter with complete medium supplemented with antibiotics.
After 14 days, spheroids (approximately 600 µ m in diameter) were
exposed to test compounds in suspension in MEM supplemented
with 5% FBS at 37˚C using the same cell density for each experi-
mental point. Selection of ‘inner’ and ‘outer’ cells within V79
spheroids was performed using two methods: Hoechst 33342
(Sigma, Missassauga Ont, Canada) cell sorting as described
previously (Durand, 1982) or sequential trysinization (Olive et al,
1993). 
Comet assay methodologies 
2 × 104 cells, suspended in 0.5 ml ice-cold PBS, were mixed with
1.5 ml 1% low gelling temperature agarose (Sigma type VII
prepared at 40˚C) in a 5 ml disposable tube. The mixture was
rapidly pipetted onto a half-frosted (for the alkaline comet assay)
or a fully frosted (for the neutral comet assay) microscope slide
and allowed to gel for approximately 1 min at room temperature. 
A cellular lysis performed under alkaline conditions led to the
elimination of cell membranes and proteins and to the unwinding
of the DNA from a double-stranded conformation to a single-
stranded conformation. Therefore, during electrophoresis, frag-
ments of DNA could be dissociated from the chromatid depending
on whether SSBs and/or DSBs had been induced by the test drug.
Thus, SSBs and DSBs were detected using an alkaline lysis solu-
tion containing 1.2 M NaCl, 30 mM NaOH, 0.5% Sarkosyl. Slides
were incubated in this lysis solution for 1 hour in the dark, at room
temperature. Slides were then rinsed 3 times by immersion for 20
minutes in 30 mM NaOH, 1 mM EDTA. Alkaline electrophoresis
was performed in a solution of 30 mM NaOH, 1 mM EDTA at
0.6 V cm–1 for 25 minutes. Finally, slides were neutralized with a
large volume of water and stained for 20 minutes in 2.5 µ g ml–1
propidium iodide. 
The use of neutral, instead of alkaline, conditions for cellular
lysis led to the elimination of cell membranes and proteins, but did
not allow the DNA to denature. Therefore, after neutral conditions
the comet tails consist of relaxed DNA loops (Klaude et al, 1996),
which migrate easier during electrophoresis when DSBs had
been induced by the test drug. Thus, DSBs could be detected
predominantly using the neutral comet assay. For neutral lysis,
slides were carefully immersed for 4 hours in a lysing solution
constituted by 30 mM EDTA, 0.5% SDS pH 8 and 0.1 mg ml–1 of
proteinase K at 50˚C. Slides were then washed 3 times in a large
volume of TBE buffer (90 mM Tris, 2 mM EDTA, 90 mM boric
acid pH 8.5) for 4–16 hours before performing electrophoresis at
0.6 V cm–1 for 25 minutes. Slides were rinsed with water and
stained for 1 hour in 2.5 µ g ml–1 propidium iodide. 
Image analyses 
Comets were viewed using a Zeiss epifluorescence microscope
combined with an intensified solid phase CCD camera and an 25 ×
objective, as detailed previously by Olive et al (1990). Each image
of an individual comet was analysed and the following features
were determined: (i) area of the comet; (ii) DNA content; (iii) per-
centage of DNA in the head and in the tail; (iv) mean position of
the head and tail, (v) head diameter and (vi) tail length, as defined
by Olive et al (1990). For each comet, all these parameters could
be compared and analysed, but the two main parameters usually
used are the ‘tail moment’ (TM), defined as the product of the
percentage of DNA in the tail multiplied by the tail length and the
‘DNA content’, defined as the total fluorescence above back-
ground, and both these parameters were calculated. Each experi-
ment was performed at least 3 times, and for each experimental
point, 100 comets were analysed and the mean TM was calculated.
Data are then presented as the mean (±SD) of these mean TM
values. 
RESULTS 
Detection of DNA damage induced by F 11782,
etoposide or camptothecin 
Initially, the induction of DNA damage after a 1 hour exposure to
either F 11782, etoposide or camptothecin, in terms of SSBs and
DSBs, in V79 monolayer cells were evaluated and compared using
the alkaline comet assay. F 11782 induced only limited DNA
damaging activity (Figure 2). A low level of DNA-strand breaks
was induced with concentrations of F 11782 up to 10 µ M, but then
this induction appeared to plateau or increased only slightly, irres-
pective of increasing concentrations of F 11782 up to 100 µ M.
This limited DNA damaging activity contrasted with the observed
DNA damage which increased markedly with increasing con-
centrations from 1 to 10 µ M of either etoposide or camptothecin
(Figure 2). A previous study of cytotoxicity evaluated by clono-
genic assay and using V79 cells showed that, after 24 hours of
exposure to the drug, the cytotoxicity of F 11782 was character-
ized by an IC50 value of 1.7 µ M (Etiévant et al, 1999), which is
consistent with the concentrations inducing DNA damage in this
report. Moreover, this IC50 value was higher than those for either
etoposide or camptothecin (respectively 0.7 and 0.08 µ M), evalu-
ated concurrently, indicating that F 11782 was less cytotoxic than
the two other compounds. This lower cytotoxicity may be related
to the low amount of damage induced by F 11782. However, any
strict relationship between cytotoxicity and the amount of damage
cannot really be established since cytotoxicity depends not only on
the amount, but also on the type of damage induced. Indeed a
previous study by Olive and Johnston has demonstrated that the
amount of strand breakage necessary to kill cells was different for
each compound tested (Olive and Johnston, 1997). Time-dependency of DNA damage induced by F 11782 
To determine whether the DNA damaging activity of F 11782
depended on time, time-course experiments were performed using
V79 cells exposed to each of the three drugs and the results are
shown in Figure 3. The concentration of each drug was selected so
as to obtain a comparable maximum mean TM of approximately
15. Under these conditions, the number of DNA-strand breaks
induced by 100 µ M F 11782 increased linearly with time over 
4 hours, whilst those induced by etoposide or camptothecin
appeared to reach a maximum after a 1 hour incubation and then
either plateaued, in the case of 3.2 µ M etoposide, or tended to
decrease with time, in the case of 5.6 µ M camptothecin. Indeed,
with camptothecin 38% of the total damage induced was no longer
apparent after 4 hours of incubation. Thus, the time-dependency of
DNA-strand break induction appears specific for F 11782 and is
probably one factor implicated in its time-dependent cytotoxicity
shown in a previous study (Etiévant et al, 1999). The rate of induc-
tion of these DNA-strand breaks induced by F 11782 was next
investigated and the data in Figure 4 illustrate that this induction
increased with time of exposure, up to 12 hours, using a range of
concentrations of F 11782. Thus, for example, 1 µ M F 11782
which did not result in any DNA-strand breakage after 1 hour,
clearly induced DNA-strand breaks after 12 hours of incubation. 
Rejoining of DNA-strand breaks induced by F 11782,
etoposide or camptothecin 
The time-dependent increase of DNA damage induced by F 11782
might be due to a lack of repair of such damage. To explore this
hypothesis, the ability to rejoin DNA-strand breaks induced by
either F 11782, etoposide or camptothecin was then investigated
(Figure 5). Again, for these experiments, the concentration and the
duration of exposure were selected for each drug so as to induce an
amount of DNA-strand breakage corresponding to an arbitrary
mean TM of 15. Following this defined exposure to the test drug,
cells were then washed 3 times with fresh medium and re-
incubated in drug-free medium for various times up to 1 hour. The
DNA-strand breaks induced by F 11782 clearly proved reversible,
decreasing linearly during the first 30 minutes of reincuba-
tion. This initial reversion though then appeared to cease after 
40 minutes, with some residual DNA-strand breaks remaining
detectable. With etoposide or camptothecin, the TM values fell
rapidly with time before plateauing. These data therefore provide
evidence of the rejoining of DNA-strand breaks induced by 
F 11782, etoposide or by camptothecin, under these experimental
conditions. The DNA-strand breaks induced by camptothecin
appeared most readily rejoined, since 70% of the damage was
‘repaired’ within 10 min, a result consistent with the fact that
camptothecin induces mainly SSBs, as opposed to DSBs, and such
damage is known to be repaired very rapidly (Olive et al, 1990;
1742 J-M Barret et al 
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Figure 2 Induction of DNA-strand breaks after a 1-hour drug exposure.
V79 monolayer cells were exposed for 1 hour to a series of concentrations of
either F 11782 (   ), etoposide (  ) or camptothecine (  ) and then alkaline
comet assays were performed. For each concentration of drug, mean TMs
(±SD) resulting from at least three experiments containing 100 cells per
experimental points were calculated
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Figure 3 Induction of DNA-strand breaks after drug exposure for 1 to 4
hours. V79 monolayer cells were exposed for various periods of time to either
100 µ M etoposide (  ) or to 5.6 µ M camptothecin (  ) and then alkaline
comet assays were performed. These concentrations were selected so as to
obtained a comparable maximum of mean TM of approximately 15. For each
drug and each time of incubation, mean TMs (±SD) resulting from at least 3
experiments containing 100 cells per experimental points were calculated
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Figure 4 Induction of DNA-strand breaks in V79 cells by F 11782. V79
monolayer cells were exposed to a series of concentrations of F 11782 for
1 (   ), 4 (  ) or 12 hours (  ) and then alkaline comet assays were performed.
For each experimental point, mean TMs (±SD) resulting from at least 3
experiments containing 100 cells per experimental points were calculatedOlive and Johnston, 1997). On the other hand, the DNA-strand
breaks induced by F 11782 appeared to be slightly less readily
rejoined, than those induced by etoposide, confirming earlier find-
ings (Barret et al, 1999). Overall, these data suggest that the rate of
strand-break repair of damage induced by the 3 drugs could be
classified as following: camptothecin > etoposide > F 11782. 
Proportion of single- and double-strand breaks induced
by F 11782, etoposide or camptothecin 
Since SSBs and DSBs are repaired by different mechanisms which
have differing kinetics, the proportion of SSBs and DSBs induced
by F 11782 had next to be evaluated. Thus, the DSBs induced were
evaluated using the neutral comet assay procedure, in addition to
the evaluation of SSBs and DSBs using the alkaline comet assay.
Under these conditions a ratio of TM for alkaline and neutral assay
(A/N ratio) could be calculated. This ratio is defined by the slopes
of the dose–response curves obtained using alkaline comet assays
divided by those of the dose–response curves obtained using
neutral comet assays. This methodology was initially described by
Olive and Johnston (1997) and they defined an A/N ratio of 14 or
18 for etoposide or X-rays, both known to induce cell death mainly
by their DSBs induction. With F 11782, an A/N ratio of 18 was
found (Figure 6A), indicating that F 11782 induced a large
proportion of DSBs. Such a result was comparable in this study 
with the A/N ratios of 24 obtained with etoposide (Figure 6B).
Similar experiments performed using camptothecin yielded a
considerably higher A/N ratio of 69 (Figure 6C), consistent with
the fact that camptothecin induces predominantly SSBs. 
Cell-cycle dependency of DNA damage induced by 
F 11782, etoposide or camptothecin 
To evaluate the hypothesis that DNA strand breaks induced by 
F 11782 might be accumulated though the cell cycle, the cell-cycle
dependency of the DNA damaging activities of F 11782 in
comparison to the two other test drugs was also investigated. Since
both DNA content and DNA damage are determined for each cell,
Catalytic inhibitor of topoisomerases induces DNA damage 1743
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Figure 5 Rejoining of DNA-strand breaks. V79 monolayer cells were
exposed for 4 hours to 100 µ M F 11782 (   ) or for 1 hour to either 3.2 µ M
etoposide (  ) or to 5.6 µ M camptothecin (  ) and then cells were washed 3
times with fresh medium and incubated at 37°C in drg-free medium for
variable times before performing alkaline comet assays. These
concentrations and incubation times were selected to obtain a comparable
maximum of mean TM. For each incubation time and each drug, mean TMs
(±SD) resulting from at least 3 experiments containing 100 cells per
experimental points were calcuated
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Figure 6 Induction of SSBs and DSBs. V79 monolayer cells were exposed
to various concentrations of either F 11782 (A), etoposide (B) or
camptothecin (C) and then alkaline (   ) or neutral (  ) Comet assays were
performed. For each concentration of drug, mean TMs (± SD) resulting from
at least 3 experiments containing 100 cells per experimental points were
calculated. The SSB/DSB ratio, corresponding to the ratio of the two slopes,
was indicated for each drug 1744 J-M Barret et al 
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it is possible to plot the amount of DNA damage accumulated in
cells containing specific amounts of DNA, i.e. those in the
different phases of the cell cycle. Figure 7 represents a compara-
tive plot of the calculated TM versus the DNA content of a series
of 100 individual cells exposed either to 100 µ M F11782 (Figure
7A) for 2 hours or to 1.0 µ M etoposide (Figure 7B) or 3.2 µ M
camptothecin (Figure 7C) for 1 hour. These experimental condi-
tions were selected so as to obtain a comparable amount of damage
by each drug, corresponding to a mean TM value of 10.5 (±1).
Cells with a DNA content around 5 are judged as being in the G1
phase of the cell cycle, those with a content of 10 are considered
in the G2/M phases, whilst those with an intermediate value
approximating to 7.5 are considered as being in S phase. The data
shown in Figure 7 provide no evidence of any clear cell cycle
specificity for the DNA damage induced by either F 11782 (Figure
7A) or etoposide (Figure 7B) under these experimental conditions.
DNA damage appears slightly higher in the G1 and S phases than
in the G2/M phases for both these test compounds, a finding previ-
ously described with etoposide (Olive and Banáth, 1993), but this
apparent difference is only marginal. On the other hand, the DNA-
strand breaks induced by camptothecin appeared with a clear
specificity in the S phase of the cell cycle (Figure 7C). 
Detection of DNA damage induced by F 11782 in V79
spheroids 
Finally, the DNA damaging activity of F 11782 in V79 spheroids
was investigated since V79 spheroids were found to be 4-fold less
sensitive to F 11782 than V79 cells cultured as monolayers
(Etiévant et al, 1999). In this study, two populations of cells
obtained from the inner and outer regions of multicellular
spheroids were obtained employing the two different protocols
described in the Methods section and originally detailed by Olive
et al (1993). Both techniques led to similar results, but the method
using Hoechst 33342 proved more appropriate for clearly selecting
the inner versus the outer populations of cells. Using this protocol,
the DNA damage induced in these ‘inner’ or ‘outer’ cell popula-
tions following treatment with F 11782 or water, as the solvent
control, is depicted in Figure 7. Means of TMs corresponding to
the ‘inner’ and ‘outer’ cells, tested with water, were respectively
1.1 ± 0.4 and 1.7 ± 0.4, indicative of the basal levels of 
DNA-strand breaks in these two populations. With the ‘outer’
population of cells, the higher mean TM value obtained (1.7 versus
1.1 with the ‘inner’ cells) was consistent with the higher replica-
tive activity of this cellular population. On the other hand, after a
4-hour incubation of spheroids with 300 µ M F 11782, the mean
TMs measured for the ‘inner’ and ‘outer’ populations of cells were
respectively 2.2 ± 1.2 and 7.4 ± 2.4. These data therefore suggest
that F 11782 induces DNA-strand breaks preferentially in the
‘outer’ population of cells, namely the replicative cells. 
Nevertheless, the differential activity of F 11782 against ‘inner’
and ‘outer’ cells might be related to other factors which remained
to be investigated like oxygenation, nutrient supply, etc.
(Sutherland, 1988). However, interestingly, a difference in DNA
damaging activity and cytotoxicity between the ‘inner’ and ‘outer’
cells of V79 spheroids has also been described for etoposide in
earlier studies (Olive et al, 1993, 1997). 
DISCUSSION 
F 11782 is a novel dual inhibitor of topoisomerase I and II which
showed in vitro inhibitory activity against the DNA binding of
topoisomerases without the stabilization of cleavable complexes,
unlike the topoisomerase poisons (Perrin et al, 2000). Con-
sequently, F 11782 was considered as a novel catalytic inhibitor of
these topoisomerases. However, F 11782 appeared a somewhat
atypical catalytic inhibitor since DNA-strand breaks were
observed in cells treated by F 11782 (Barret et al, 1999).
Moreover, the appearance of DNA-strand breaks was not related to
protein/DNA complex formation (Perrin et al, 1999), but appeared
to be correlated with the cytotoxicity of F 11782 (Barret et al,
1999). At this time, the relationship between the activities of 
F 11782 vis-a-vis the purified topoisomerases and the appearance
of cellular DNA-strand breaks remained unclear. Thus, a char-
acterization of DNA-strand breaks induced by F 11782 appeared
important in terms of elucidating its precise mode of action. 
The DNA damage induced by F 11782 in V79 cells was investig-
ated using both alkaline and neutral versions of the comet assay.
These experiments demonstrated that F 11782 initially induced
only limited DNA damaging activity, as observed in a previous
study with other cell lines and using different detection techniques
(Barret et al, 1999; Perrin et al, 1999). However the number of
DNA-strand breaks induced in V79 cells by F 11782 increased
linearly with time. These results indicate that the amount of DNA-
strand breakage induced by F 11782 accumulated with respect to
time and was not dependent only on the concentration of F 11782.
Thus, the DNA-damaging activity of F 11782 appeared to involve
a cumulative cellular process, the nature of which remains to be
determined. A study of the DNA damaging activity of F 11782 in
V79 spheroids suggested that F 11782 induced DNA-strand breaks
preferentially in the ‘outer’ population of cells, namely the replica-
tive cells, implying that the DNA-strand breaks induced by
F 11782 involved protein(s) involved in cell replication. Such a
result would be consistent with an interaction of F 11782 with
topoisomerases, without ruling out additional interaction(s).
Moreover, DNA strand-breaks induced by F 11782 appeared
throughout the cell cycle without any specificity for one particular
phase of cycle. 
Thus, this induction of DNA-strand breaks by F 11782 did not
involve a cell cycle phase-dependent process. On the other hand,
these DNA-strand breaks included a larger proportion of DSBs
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Figure 7 Bivariate plots showing characteristic changes in DNA damage as
a function of cell cycle position. V79 monolayer cells were exposed for 2
hours to 100 µ M F 11782 (A), for 1 hour to 1.0 µ M etoposide (B) or for 1 hour
to 3.2 µ M camptothecin (C). These conditions were selected to compare the
three profiles obtained with an equivalent mean TM of 10.5 ± 1. Alkaline
comet assay was performed as detailed in ‘Materials and Methods’ and
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versus SSBs, comparable to damage induced by X-rays (Olive and
Johnston, 1997) and such damage appeared reversible at least in
part, as shown by the rejoining of DNA-strand breaks following
incubation in drug-free medium. To assess the significance of this
DNA damage induced by F 11782 in terms of its dual inhibitory
activity against topoisomerases I and II, a comparison was made of
the DNA-strand breakage induced by F 11782 with that induced
by either camptothecin or by etoposide, two topoisomerase poisons
which induce predominantly and respectively SSBs and DSBs.
A comparison of the damage resulting from exposure to
F 11782 with that induced by camptothecin clearly demonstrated
their different nature. The appearance and reversibility of strand-
breaks induced by camptothecin was more rapid than those
induced by F 11782. These results relate to the nature of the DNA-
strands breaks induced, since with camptothecin the proportion of
SSBs induced was much greater than those induced using F 11782.
Furthermore, whilst the DNA-damaging activity of camptothecin
is clearly concentrated during the S phase of the cell cycle, no such
cell cycle specificity was observed with F 11782. In conclusion,
the mechanism(s) leading to DNA-strand breaks and to cytotoxi-
city are certainly different vis-a-vis F 11782 and camptothecin.
Such data would be expected if F 11782 was shown to inhibit
topoisomerase I by a mechanism different from that of campto-
thecin (Perrin et al, 2000), which might not be essential for its
cytotoxicity. Complementary studies using cell lines expressing
different amounts or mutated form of topoisomerase I to further
elucidate this aspect are ongoing. 
The nature of DNA-strand breaks induced by F 11782 and
etoposide though were less easily distinguishable. Indeed, the
DNA-damaging activities of these two drugs throughout the cell
cycle were similar and the proportion of SSBs and DSBs induced
were essentially comparable. DNA-strand break induction by 
F 11782 and etoposide was also similar in relation to their 
relative effects versus ‘inner’ and ‘outer’ cells of V79 spheroids.
Nevertheless, one major difference has been highlighted between
the DNA damage induced by F 11782 and that induced by etopo-
side and this involves the time-dependency of the appearance of
DNA-strand breaks. In parallel, uptake studies using P388 cells
the rate and extent of accumulation of F 11782 and etoposide were
comparable (data not shown). So a slower or reduced accumula-
tion of F 11782 is unlikely to explain this time dependency.
Nevertheless, the fact that DNA damage induced by F 11782
increased with the time of incubation strongly suggested that the
appearance of DNA-strand breaks resulted from a mechanism
which came into play after the preliminary interaction between
F 11782 and topoisomerase, whilst those induced by etoposide
occurred immediately after its addition and resulted from the stabi-
lization of cleavable complexes. Thus, unlike etoposide, the first
event which leads to cytotoxicity with F 11782 might not be the
induction of DNA damage. The slower rate of rejoining of the
DNA-strand breaks induced by F 11782, as opposed to etoposide,
is probably insufficient to explain such a differential accumula-
tion of DNA-strand breaks with these two test compounds.
Nevertheless, the reversion of DNA-strand breakage was
measured in the absence of F 11782. Thus, in addition to its DNA-
damaging activity, an inhibitory effect of F 11782 on DNA-strand
break repair mechanisms cannot be ruled out. Such an activity has
already been suggested by a previous study using DNA repair
deficient cells (Barret et al, 1999), where xrs-6 cells, deficient in
Ku 86 and thus deficient in non-homologous recombination, were
shown to be 3-fold more sensitive to F 11782 than the parental
CHO-Kl cells, whilst they were around 10-fold more sensitive to
etoposide. Thus, the presence of Ku only partially influenced the
cytotoxicity of F 11782 in these cells. This finding could be
explained not only in terms of a different type and/or a different
amount of damage being induced by these two drugs, but also by a
concomitant and selective effect of F 11782 on the Ku-dependent
repair pathway. Thus, F 11782 which can induce a low level of
DNA-strand breaks, coupled with its interference with DNA repair
process could lead to an accumulation of DNA-strand breaks with
time. Such an hypothesis remains to be confirmed by testing
F 11782 against cells deficient in different repair pathways and
against cells deficient in other genes involved in non-homologous
recombination, the predominant DBSs repair pathway. Since
F 11782 has already proved a potent inhibitor of topoisomerases 
I and II, inhibitory activity against topoisomerase III also cannot
be ruled out. Such an inhibition might explain the influence of
F 11782 on DBSs repair since the activity of topoisomerase III was
recently found to be related to DNA recombination (Nitiss, 1998;
Ng et al, 1999). This aspect remains to be explored, but, neverthe-
less, the time-dependent activity of F 11782 is certainly a crucial
factor in its apparently unique mechanism of action and may
account, at least in part, for its high level of in vivo antitumour
activity (Kruczynski et al, 1999). 
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